Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk
Thomas, Gregory S., MD, MPH, Cromwell, William C., MD, Ali, Shariq, PhD, Chin, Wai, PhD, Flaim, JoAnn D., PhD, Davidson, Michael, MD
Published in Journal of the American College of Cardiology (10.12.2013)
Published in Journal of the American College of Cardiology (10.12.2013)
Get full text
Journal Article
Safety and Efficacy of Mipomersen Administered as Add-on Therapy in Patients with Hypercholesterolemia and High Cardiovascular Risk
Cromwell, William C., MD, Thomas, Gregory S., MD, MPH, Boltje, Ingrid, MD, Chin, Wai, PhD, Davidson, Michael, MD
Published in Journal of clinical lipidology (01.05.2012)
Published in Journal of clinical lipidology (01.05.2012)
Get full text
Journal Article